JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia	B-ALL; B-NHL	Recruiting	Not applicable	2025-07-08		NCT06689917

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Tongji Hospital	276

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China	Wuhan	China	1

Clinical trials